Drug enterohepatic circulation and disposition: constituents of systems pharmacokinetics
- PMID: 24295642
- DOI: 10.1016/j.drudis.2013.11.020
Drug enterohepatic circulation and disposition: constituents of systems pharmacokinetics
Abstract
Drug disposition information constitutes a part of systems pharmacokinetics, and becomes imperative when a drug shows significant effects at its disproportionally low blood concentration. The situation could result from outweighing the parent drug in tissues over in blood and/or from its active metabolites. Fractions of certain drugs absorbed from the intestine to the systemic circulation via the portal vein can return to the intestine via the bile duct and the sphincter of Oddi - a complementary nonrenal elimination route termed the enterohepatic circulation (EHC). Here, we critically evaluate the existing methods, techniques and animal models used for determining drug distribution, elimination and EHC, and collectively portray characteristics of 43 drugs that undergo EHC. EHC could represent an unexplored way to excrete unwanted substrates out of the body. The interdisciplinary analysis galvanizes our efforts to overcome technical gaps in drug discovery and development.
Copyright © 2013 Elsevier Ltd. All rights reserved.
Similar articles
-
Model systems for pharmacokinetics of steroid drugs subject to enterohepatic circulation.Exp Clin Endocrinol. 1986 Jul;87(2):118-24. doi: 10.1055/s-0029-1210532. Exp Clin Endocrinol. 1986. PMID: 3758191
-
A reversible clearance model for the enterohepatic circulation of drug and conjugate metabolite pair.Drug Metab Dispos. 1990 Jan-Feb;18(1):80-7. Drug Metab Dispos. 1990. PMID: 1970782
-
Prediction of human pharmacokinetics-biliary and intestinal clearance and enterohepatic circulation.J Pharm Pharmacol. 2008 May;60(5):535-42. doi: 10.1211/jpp.60.5.0001. J Pharm Pharmacol. 2008. PMID: 18416932 Review.
-
Evaluation of intestinal absorption into the portal system in enterohepatic circulation by measuring the difference in portal-venous blood concentrations of diclofenac.Pharm Res. 1995 Jun;12(6):880-3. doi: 10.1023/a:1016217221977. Pharm Res. 1995. PMID: 7667194
-
Efficiency of enterohepatic circulation, its determination and influence on drug bioavailability.Arzneimittelforschung. 1999 Oct;49(10):805-15. doi: 10.1055/s-0031-1300506. Arzneimittelforschung. 1999. PMID: 10554656 Review.
Cited by
-
Pharmacokinetic Simulation and Area under the Curve Estimation of Drugs Subject to Enterohepatic Circulation.Pharmaceutics. 2024 Aug 6;16(8):1044. doi: 10.3390/pharmaceutics16081044. Pharmaceutics. 2024. PMID: 39204389 Free PMC article.
-
Importance of Considering Fed-State Gastrointestinal Physiology in Predicting the Reabsorption of Enterohepatic Circulation of Drugs.Pharm Res. 2024 Apr;41(4):673-685. doi: 10.1007/s11095-024-03669-3. Epub 2024 Mar 12. Pharm Res. 2024. PMID: 38472609 Free PMC article.
-
Enteric reabsorption processes and their impact on drug pharmacokinetics.Sci Rep. 2021 Mar 11;11(1):5794. doi: 10.1038/s41598-021-85174-w. Sci Rep. 2021. PMID: 33707635 Free PMC article.
-
Predicting drug-metagenome interactions: Variation in the microbial β-glucuronidase level in the human gut metagenomes.PLoS One. 2021 Jan 7;16(1):e0244876. doi: 10.1371/journal.pone.0244876. eCollection 2021. PLoS One. 2021. PMID: 33411719 Free PMC article.
-
Charactering the metabolism of cryptotanshinone by human P450 enzymes and uridine diphosphate glucuronosyltransferases in vitro.Acta Pharmacol Sin. 2018 Aug;39(8):1393-1404. doi: 10.1038/aps.2017.144. Epub 2018 Feb 8. Acta Pharmacol Sin. 2018. PMID: 29417949 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources